A 27-year-old woman with HIV presents to clinic to establish care. Routine screening for sexually transmitted infections, including Trichomonas vaginalis, is done and is positive for T. vaginalis.
Which one of the following is recommended to treat trichomoniasis in women with HIV?

Figure 1. Treatment of Trichomoniasis in Women with HIV with Single Dose or 7-Day Course of Metronidazole
In this trial women with HIV who were diagnosed with trichomoniasis were randomized to receive either metronidazole 500 mg orally twice daily for 7 days or metronidazole 2 g orally in a single dose. Women receiving the single-dose therapy clearly had higher failure rates.
Souce: Kissinger P, Mena L, Levison J, et al. A randomized trial: a single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women. J Acquir Immune Defic Syndr. 2010;55;565-71.
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
January 29th, 2025
January 29th, 2025
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5